UNSPSC 51161570: Nisbuterol mesilate or mesylate

This classification denotes an anti-asthmatic agent with the molecular formula C22H27NO6.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4ZSF6GBG5S, chemically known as benzoic acid, 4-methoxy-, 2-(acetyloxy)-4-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)phenyl ester, methanesulfonate (salt) but more generally known as nisbuterol mesylate, which bears US NIH Compound Identifier 3047792. Most nations, for tariff and trade purposes, schedule nisbuterol mesylate under HS 29225000.

As of Q4 2014, NISBUTEROL MESYLATE remains US FDA's Preferred Term for this commodity. Nisbuterol mesylate bears US NLM identifiers UMLS ID C2698474 and NCI Concept Code C75139. SMILES: CC(=O)OC1CC(CCC1OC(=O)C2CCC(CC2)OC)C(CNC(C)(C)C)O.CS(=O)(=O)O.

UNSPSC 51161570 Nisbuterol mesilate or mesylate is a Commodity code for a pharmaceutical active ingredient used in bronchodilator formulations. State and local governments procure this substance primarily through health department pharmaceutical acquisitions, correctional facility medical supply contracts, and public health agency sourcing for emergency preparedness stockpiles. The work involves specification and procurement of the raw chemical compound to pharmaceutical-grade standards, typically bundled with other respiratory therapeutics or purchased as part of broad pharmaceutical frameworks. Issuing bodies soliciting under this code are state health departments, state correctional agencies, and municipal public health departments; individual school districts and transit authorities rarely appear as direct buyers for this commodity.

The code shows limited recent solicitation activity across state and local procurement channels. No recent state or local contract opportunities were identified in the current opportunity records for this specific commodity code. Procurement under this code is typically embedded within larger pharmaceutical supply agreements or emergency medical stockpile contracts rather than issued as standalone RFPs, RFQs, or ITBs targeting the ingredient by name. Business development professionals should monitor state health department and corrections agency pharmaceutical framework agreements and broad-based medical supply RFPs, where nisbuterol mesilate may appear as a line item or included therapeutic, rather than expect discrete opportunities tagged to this commodity code.